Logo image of MDT

MEDTRONIC PLC (MDT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MDT - IE00BTN1Y115 - Common Stock

105.33 USD
+0.31 (+0.3%)
Last: 11/28/2025, 7:45:42 PM
105.33 USD
0 (0%)
After Hours: 11/28/2025, 7:45:42 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MDT. MDT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. MDT has an excellent profitability rating, but there are some minor concerns on its financial health. MDT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MDT had positive earnings in the past year.
In the past year MDT had a positive cash flow from operations.
MDT had positive earnings in each of the past 5 years.
Each year in the past 5 years MDT had a positive operating cash flow.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

MDT has a better Return On Assets (5.22%) than 81.91% of its industry peers.
MDT has a Return On Equity of 9.79%. This is amongst the best in the industry. MDT outperforms 85.64% of its industry peers.
MDT has a better Return On Invested Capital (6.63%) than 81.38% of its industry peers.
MDT had an Average Return On Invested Capital over the past 3 years of 6.35%. This is below the industry average of 8.72%.
The 3 year average ROIC (6.35%) for MDT is below the current ROIC(6.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROIC 6.63%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 13.71%, MDT belongs to the best of the industry, outperforming 89.36% of the companies in the same industry.
MDT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 19.42%, MDT belongs to the top of the industry, outperforming 93.09% of the companies in the same industry.
MDT's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 65.57%, MDT is in the better half of the industry, outperforming 68.62% of the companies in the same industry.
In the last couple of years the Gross Margin of MDT has remained more or less at the same level.
Industry RankSector Rank
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDT is destroying value.
Compared to 1 year ago, MDT has less shares outstanding
Compared to 5 years ago, MDT has less shares outstanding
Compared to 1 year ago, MDT has a worse debt to assets ratio.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

MDT has an Altman-Z score of 3.20. This indicates that MDT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.20, MDT is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
The Debt to FCF ratio of MDT is 5.59, which is a neutral value as it means it would take MDT, 5.59 years of fcf income to pay off all of its debts.
MDT has a Debt to FCF ratio of 5.59. This is in the better half of the industry: MDT outperforms 78.19% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that MDT is somewhat dependend on debt financing.
MDT has a worse Debt to Equity ratio (0.57) than 61.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Altman-Z 3.2
ROIC/WACC0.99
WACC6.72%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 2.42 indicates that MDT has no problem at all paying its short term obligations.
MDT has a Current ratio (2.42) which is in line with its industry peers.
A Quick Ratio of 1.80 indicates that MDT should not have too much problems paying its short term obligations.
MDT has a Quick ratio of 1.80. This is comparable to the rest of the industry: MDT outperforms 45.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.8
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.24% over the past year.
MDT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.68% yearly.
The Revenue has been growing slightly by 5.34% in the past year.
The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%

3.2 Future

Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 6.35% on average per year.
The Revenue is expected to grow by 5.79% on average over the next years.
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.29%
EPS Next 5Y6.35%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y6.21%
Revenue Next 5Y5.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

MDT is valuated rather expensively with a Price/Earnings ratio of 18.71.
Based on the Price/Earnings ratio, MDT is valued cheaper than 82.98% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. MDT is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 17.17, which indicates a rather expensive current valuation of MDT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDT indicates a rather cheap valuation: MDT is cheaper than 83.51% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MDT to the average of the S&P500 Index (36.56), we can say MDT is valued rather cheaply.
Industry RankSector Rank
PE 18.71
Fwd PE 17.17
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDT is valued cheaper than 82.98% of the companies in the same industry.
83.51% of the companies in the same industry are more expensive than MDT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.95
EV/EBITDA 15.24
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDT does not grow enough to justify the current Price/Earnings ratio.
MDT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.64
PEG (5Y)5.08
EPS Next 2Y5.62%
EPS Next 3Y6.29%

6

5. Dividend

5.1 Amount

MDT has a Yearly Dividend Yield of 2.70%.
Compared to an average industry Dividend Yield of 1.71, MDT pays a better dividend. On top of this MDT pays more dividend than 98.40% of the companies listed in the same industry.
MDT's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.7%

5.2 History

The dividend of MDT has a limited annual growth rate of 5.10%.
MDT has paid a dividend for at least 10 years, which is a reliable track record.
MDT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.1%
Div Incr Years11
Div Non Decr Years11
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

MDT pays out 75.86% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP75.86%
EPS Next 2Y5.62%
EPS Next 3Y6.29%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

NYSE:MDT (11/28/2025, 7:45:42 PM)

After market: 105.33 0 (0%)

105.33

+0.31 (+0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/bmo
Earnings (Next)02-17 2026-02-17/bmo
Inst Owners87.1%
Inst Owner Change0.39%
Ins Owners0.29%
Ins Owner Change3.84%
Market Cap135.10B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts72.82
Price Target103.15 (-2.07%)
Short Float %1.13%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 2.7%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years11
Div Non Decr Years11
Ex-Date09-26 2025-09-26 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)2.58%
PT rev (3m)2.89%
EPS NQ rev (1m)-0.71%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)0.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 18.71
Fwd PE 17.17
P/S 3.89
P/FCF 25.95
P/OCF 18.99
P/B 2.78
P/tB N/A
EV/EBITDA 15.24
EPS(TTM)5.63
EY5.35%
EPS(NY)6.14
Fwd EY5.83%
FCF(TTM)4.06
FCFY3.85%
OCF(TTM)5.55
OCFY5.27%
SpS27.1
BVpS37.93
TBVpS-3.06
PEG (NY)5.64
PEG (5Y)5.08
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROCE 8.29%
ROIC 6.63%
ROICexc 7.39%
ROICexgc 26.33%
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
FCFM 14.98%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Debt/EBITDA 2.83
Cap/Depr 63.21%
Cap/Sales 5.49%
Interest Coverage 8.53
Cash Conversion 72.83%
Profit Quality 109.28%
Current Ratio 2.42
Quick Ratio 1.8
Altman-Z 3.2
F-Score8
WACC6.72%
ROIC/WACC0.99
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.29%
EPS Next 5Y6.35%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y6.21%
Revenue Next 5Y5.79%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year19.44%
EBIT Next 3Y11.21%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (MDT) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


Can you provide the valuation status for MEDTRONIC PLC?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


How profitable is MEDTRONIC PLC (MDT) stock?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of MEDTRONIC PLC (MDT) stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 18.71 and the Price/Book (PB) ratio is 2.78.


Can you provide the financial health for MDT stock?

The financial health rating of MEDTRONIC PLC (MDT) is 5 / 10.